Overtreatment of older men with prostate cancer raises concerns

Increasing percentages of some older U.S. men with intermediate-risk and high-risk prostate cancers are undergoing treatments that carry risks of side effects that can significantly reduce the quality of life without extending life, according to a new study led by Cedars-Sinai.

Philips Receives FDA 510(k) Clearance on Image-Guided Surgical Therapy

What You Should Know: – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced its Philips Zenition 30 mobile C-arm has

April 24, 2024

First targeted alpha therapy wins FDA breakthrough device designation – Pharmaceutical Technology

Share this article By coupling the alpha particle emitting radioisotopes to tumour-selective carrier molecules, cancer cells can be targeted while leaving healthy cells alone. Image

February 12, 2024

Medicare billing forms are running out of space for growing health care prices

WASHINGTON — Health care costs are getting so high that prices are literally running off of the page. Medicare on a couple of occasions recently

April 2, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.